mnk should be o k if they don`t throw in with the rest of the other bio`s that are considering B K OVER THE OPIOD CRISIS.
they have about 15 drugs in trials......a few are at stage 4
they bought ocera (ocrx) about 2 years ago for a liver drug....it was ocr-002 an ammonia scavenger....mnk renamed it MNK6106...finishing trial for hepatic cirrhosis...study end oct 30/19.....data to follow .......this could be a nice bail-out for them, if positive data........MNK was about $40/share last year
I sold a bunch of ocrx for the offer, but kept about 8000 with mnk for the milestone payments......volume is low....most traders are afraid of what other states might file against the pill pushers.......risk is high, but bargain price for this company
$$$$$$$$$$$$$$$$$$$$$ MNK $$$$$$$$$$$$$$$....glta
don`t listen to me, don`t have a clue!